Lefranc Romain, Waeckel Thibaut, Doerfler Arnaud, Tillou Xavier
Urology department, CHU de Caen, Avenue de la Côte de Nacre, Caen, 14000, France.
Urology department, CHU de Charleroi, Université libre de Bruxelles (ULB), Charleroi, 6000, Belgium.
World J Urol. 2025 Sep 18;43(1):561. doi: 10.1007/s00345-025-05900-1.
Surgical pyelonephritis (SP) encompasses severe upper urinary tract infections, including pyonephrosis, renal and perinephric abscesses, and emphysematous pyelonephritis. The 2024 EAU Guidelines classify these as complicated UTIs requiring early antibiotic therapy, hemodynamic stabilization, and prompt source control. This study aimed to reassess the role of emergency nephrectomy (EN) in SP management and to identify predictors of conservative management (CM) failure.
We conducted a retrospective, single-center study including patients treated for SP at Caen University Hospital, France, between January 2011 and December 2022.
Eighty-eight patients were included: 10 underwent primary EN, and 78 received CM, of whom 9 (11.5%) later required secondary nephrectomy (SN) due to CM failure. Renal abscesses (RA) were the most frequent indication for EN, followed by emphysematous pyelonephritis. Diabetes was significantly more prevalent in EN patients (p < 0.001). Urinary tract obstruction was observed in 30.0% of EN patients versus 82.1% of those initially treated conservatively (p = 0.001). Initial EN patients had higher severe morbidity rates than CM patients (50.0% vs. 29.5%, p = 0.04), although similar to SN patients (66.7% vs. 50.0%, p = 0.07). A high ASA score, chronic kidney disease (CKD), and smoking were associated with an increased risk of CM failure.
Surgical pyelonephritis should be managed stepwise, favoring conservative approaches when possible. Early identification of patients at risk of failure is crucial, and timely escalation to nephrectomy may improve outcomes. Biomarkers and standardized reassessment protocols may support better risk stratification.
外科性肾盂肾炎(SP)包括严重的上尿路感染,如脓肾、肾及肾周脓肿和气肿性肾盂肾炎。2024年欧洲泌尿外科学会(EAU)指南将这些归类为需要早期抗生素治疗、血流动力学稳定及迅速控制感染源的复杂性尿路感染。本研究旨在重新评估急诊肾切除术(EN)在SP治疗中的作用,并确定保守治疗(CM)失败的预测因素。
我们进行了一项回顾性单中心研究,纳入2011年1月至2022年12月期间在法国卡昂大学医院接受SP治疗的患者。
共纳入88例患者:10例行一期EN,78例接受CM,其中9例(11.5%)因CM失败后来需要二期肾切除术(SN)。肾脓肿(RA)是EN最常见的适应证,其次是气肿性肾盂肾炎。糖尿病在EN患者中显著更常见(p<0.001)。30.0%的EN患者存在尿路梗阻,而最初接受保守治疗的患者中这一比例为82.1%(p=0.001)。一期EN患者的严重并发症发生率高于CM患者(50.0%对29.5%,p=0.04),尽管与SN患者相似(66.7%对50.0%,p=0.07)。高美国麻醉医师协会(ASA)评分、慢性肾脏病(CKD)和吸烟与CM失败风险增加相关。
外科性肾盂肾炎应逐步进行治疗,尽可能采用保守方法。早期识别有失败风险的患者至关重要,及时升级至肾切除术可能改善预后。生物标志物和标准化的重新评估方案可能有助于更好地进行风险分层。